Pain Reprocessing Therapy: A Framework for Recovering from Primary Chronic Pain
Medical treatments for chronic pain are often ineffective, and psychological treatments typically view pain as a lifelong, chronic condition that can only be managed but not effectively treated. Here, we introduce a novel therapeutic framework, pain reprocessing therapy (PRT), integrating advances from neuroscience, psychology, and medicine to more effectively treat chronic pain. PRT rests on the premise that many cases of chronic pain are driven primarily by fear-avoidance learning and maladaptive functional changes in predictive processing and pain construction—termed “primary” or “neuroplas...Read moretic” pain. Critically, this suggests that cases of primary chronic pain can be “unlearned”—with symptoms mostly or completely eliminated. In a recently completed clinical trial (N = 151), 66% of patients randomized to PRT were pain-free or nearly so at post-treatment, as compared to less than 20% of controls, with gains largely maintained for 1 year post-treatment (Ashar et al., 2022 JAMA Psych). This workshop will provide clinicians an introduction to the PRT framework. Less...
Learning Objectives
- Assess for the presence of primary vs. secondary pain.
- Communicate the primary pain diagnosis effectively to patients.
- Lead a patient in an effective "somatic tracking" exercise.
Friday, March 17, 2023
71 West 23rd Street, New York, NY, 10010
09:00 AM EDT - 01:00 PM EDT
Register for this eventAbout the speakers
Yoni K. Ashar, PhD
Daniella Deutsch, ASW
Agenda
9:00-9:10: Introductions
9:10-9:50: Overview of research and evidence base on neuroplastic pain and pain reprocessing therapy
9:50-10:30: Assessing for neuroplastic pain
10:30-10:45: Break
10:45-11:15: Providing neuroplastic pain psychoeducation and troubleshooting barriers to accepting the diagnosis
11:15-11:45: Pain Safety Learning, Part 1
- Behavioral exposures
- Somatic tracking 2
11:45-12:00: Break
12:00-12:30: Pain Safety Learning, Part 2
12:30-12:50: Identifying and addressing non-pain threats
12:50-1:00: Wrap-up and further resources
Become a NYC-CBT Member and receive discounts to all of our educational lectures from top CBT professionals!
To become a member click HERE
CE Information - Earn 3.5 CE Credit Hours
CE Approvals
New York State Education Department's State Board for Social Work
New York Education Department Board of Creative Arts Therapy
New York Education Department for Licensed Mental Health Counselors
New York Education Department Board for Licensed Psychoanalysts
New York State Education Department's State Board for Psychology
New York State Education Department's State Board for Marriage and Family Therapy
CE Process Info
Each professional is responsible for the individual requirements as stipulated by his/her licensing agency. Please contact your individual licensing board/regulatory agency to review continuing education requirements for licensure renewal. Please note: You must attend "live" (in real-time) to earn CE credits.
After the event, you will receive access to your evaluation and continuing education certificate via a personalized "attendee dashboard" link, hosted on the CE-Go website. This link will be sent to the email account you used to register for the event.
Upon accessing the CE-Go "attendee dashboard", you will be able to:
- Complete evaluation forms for the event
- Download your continuing education certificate in a PDF format
If you have any questions or concerns regarding the CE-Go platform, please contact CE-Go at 888-498-5578 or by email at support@ce-go.com Please Note: Emails for this event will come from "support@ce-go.com".
If you have any continuing education related questions, please contact your event organizer.
Please make sure to check your spam/junk folder in case those emails get "stuck". We'd also suggest "Allowlisting" support@ce-go.com. This tells your email client that you know this sender and trust them, which will keep emails from this contact at the top of your inbox and out of the junk folder.
Disclosure
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPSCE Learning Systems, LLC is an independent provider of continuing medical education. CE Learning Systems, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, CE Learning Systems, LLC is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest).
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
1. Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
2. any investigational, off-label, or non-FDA approved content or discussion
CE Learning Systems, LLC has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:
1. All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
2. All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
3. Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
FACULTY
The faculty have reported the following: There are no relevant disclosures.
PLANNERS
The planners have reported the following: There are no relevant disclosures.
